 | Up a level |
2022
Terbuch, Angelika, Posch, Florian, Bauernhofer, Thomas, Jost, Philipp J. 
ORCID: 0000-0003-2454-0362, Partl, Richard, Stranzl-Lawatsch, Heidi, Baciarello, Giulia, Fizazi, Karim, Giannatempo, Patrizia, Verzoni, Elena, Sweeney, Christopher, Ravi, Praful, Tran, Ben, Basso, Umberto, White, Jeff, Vincenzi, Bruno, Oing, Christoph, Cutuli, Hernan Javier, Dieckmann, Klaus Peter, Gamulin, Marija, Chovanec, Michal, Fankhauser, Christian Daniel, Heidenreich, Axel, Mohamad, Osama, Thibault, Constance, Fischer, Stefanie and Gillessen, Silke
(2022).
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int. J. Radiat. Oncol. Biol. Phys., 113 (4).
S. 825 - 833.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1879-355X
2021
Seidel, Christoph ORCID: 0000-0002-6023-6336, Daugaard, Gedske, Nestler, Tim, Tryakin, Alexey, Fedyanin, Mikhail, Fankhauser, Christian Daniel, Hermanns, Thomas, Aparicio, Jorge, Heinzelbecker, Julia, Paffenholz, Pia, Heidenreich, Axel, De Giorgi, Ugo, Cathomas, Richard, Lorch, Anja, Fingerhut, Anna, Gayer, Fabian, Bremmer, Felix, Giannatempo, Patrizia, Necchi, Andrea, Raggi, Daniele ORCID: 0000-0002-4185-2475, Aurilio, Gaetano, Casadei, Chiara, Hentrich, Marcus, Tran, Ben, Dieckmann, Klaus-Peter, Brito, Margarido, Ruf, Christian, Mazzocca, Alessandro, Vincenzi, Bruno, Stahl, Olof, Bokemeyer, Carsten and Oing, Christoph
(2021).
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
World J. Urol., 39 (9).
S. 3407 - 3415.
NEW YORK:
SPRINGER.
ISSN 1433-8726
2020
Bruno, Tiziana, De Nicola, Francesca, Corleone, Giacomo ORCID: 0000-0002-6170-9780, Catena, Valeria ORCID: 0000-0002-9639-1944, Goeman, Frauke, Pallocca, Matteo ORCID: 0000-0002-7756-3579, Sorino, Cristina ORCID: 0000-0002-6100-289X, Bossi, Gianluca ORCID: 0000-0002-2947-1063, Amadio, Bruno, Cigliana, Giovanni, Ricciardi, Maria Rosaria, Petrucci, Maria Teresa, Spugnini, Enrico Pierluigi, Baldi, Alfonso ORCID: 0000-0002-8693-3842, Cioce, Mario, Cortese, Giancarlo, Mattei, Elisabetta, Merola, Roberta, Gianelli, Umberto, Baldini, Luca, Pisani, Francesco, Gumenyuk, Svitlana, Mengarelli, Andrea ORCID: 0000-0002-2606-2467, Hopker, Katja, Benzing, Thomas, Vincenzi, Bruno, Floridi, Aristide, Passananti, Claudio, Blandino, Giovanni, Iezzi, Simona ORCID: 0000-0002-7484-5861 and Fanciulli, Maurizio
(2020).
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma.
Blood Adv., 4 (22).
S. 5616 - 5631.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 2473-9537
D'Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna M., Piperno-Neumann, Sophie, Martin-Broto, Javier ORCID: 0000-0001-7350-6916, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Chevreau, Christine, Sherriff, Jenny, Estival, Anna, Litiere, Saskia, Sents, Ward, Ray-Coquard, Isabelle, Tolomeo, Francesco, Le Cesne, Axel, Rutkowski, Piotr, Stacchiotti, Silvia, Kasper, Bernd, Gelderblom, Hans and Gronchi, Alessandro
(2020).
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer, 126 (11).
S. 2637 - 2648.
HOBOKEN:
WILEY.
ISSN 1097-0142
Fischer, Stefanie, Tandstad, Torgrim, Cohn-Cedermark, Gabriella, Thibault, Constance, Vincenzi, Bruno, Klingbiel, Dirk, Albany, Costantine, Necchi, Andrea, Terbuch, Angelika, Lorch, Anja, Aparicio, Jorge, Heidenreich, Axel, Hentrich, Marcus, Wheater, Matthew, Langberg, Carl W., Stahl, Olof, Fankhauser, Christian Daniel, Hamid, Anis A., Koutsoukos, Konstantinos, Shamash, Jonathan, White, Jeff, Bokemeyer, Carsten, Beyer, Jorg and Gillessen, Silke ORCID: 0000-0001-5746-6555
(2020).
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J. Clin. Oncol., 38 (12).
S. 1322 - 1333.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755